# Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus

> **NCT04345107** · PHASE1 · COMPLETED · sponsor: **Suzhou Yabao Pharmaceutical R&D Co., Ltd.** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** SY-009
- **DRUG:** SY-009 matching placebo

## Key facts

- **NCT ID:** NCT04345107
- **Lead sponsor:** Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2021-04-29
- **Final completion:** 2021-09-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345107, "Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04345107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*